bu 224 has been researched along with nifedipine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Li, J; Liu, Y; Lu, XQ; Piletz, JE; Qin, BY; Su, RB; Wu, N; Xu, B; Zheng, JQ | 1 |
2 other study(ies) available for bu 224 and nifedipine
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence.
Topics: Agmatine; Animals; CHO Cells; Cricetinae; Cyclic AMP; Dizocilpine Maleate; Imidazoles; Imidazoline Receptors; Intracellular Signaling Peptides and Proteins; Morphine; Naloxone; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase | 2005 |